Structure--activity relationships within a series of 2,4-diaminoalkoxybenzene compounds. 1980

M Shahin, and D Rouers, and A Bugaut, and G Kalopissis

Six 2,4-diaminoalkoxybenzenes were examined for their ability to induce mutation in Salmonella typhimurium. Each compound was tested at 8 concentrations in 5 strains. The mutagenicity was influenced by the size of the alkoxy group substituted at the C1 position of 2,4-diaminobenzene. When S9 induced by Aroclor 1254 was present, 2,4-diaminoanisole (the methoxy derivative) exhibited the highest mutagenic activity. The compounds 2,4-diaminoethoxybenzene, 2,4-diaminoisopropoxybenzene and and 2,4-diamino-n-propoxybenzene were also mutagenic, but were distinctly less active than 2,4-diaminoanisole. With the compounds 2,4-diaminophenoxyethanol and 2,4-diamino-n-butoxybenzene, the increases in numbers of revertant colonies above control levels were slight or absent. The mutagenicity of 2,4-diaminoalkoxybenzenes was detected in strains TA98, TA1538 and in some cases TA1537. None of the compounds was active in strain TA1535. The relative response of the various strains suggests that 2,4-diaminoalkoxybenzenes induce frameshift mutations but not base-pair substitutions. None of the compounds was active without metabolic activation. In addition to conducting the standard plate test, we tested the urine of rats exposed to 2,4-diaminophenoxyethanol and 2,4-diaminoanisole for mutagenicity in Salmonella typhimurium. The rats were exposed by topical application, oral administration or intraperitoneal injection. The results were positive for 2,4-diaminoanisole and negative for 2,4-diaminophenoxyethanol.

UI MeSH Term Description Entries
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D010655 Phenylenediamines Aniline compounds that contain two amino groups. They are used as a precursor in the synthesis of HETEROCYCLIC COMPOUNDS and POLYMERS. p-Phenylenediamine is used in the manufacture of HAIR DYES and is an ALLERGEN.
D000840 Anisoles A group of compounds that are derivatives of methoxybenzene and contain the general formula R-C7H7O. Methylphenyl Ethers,Ethers, Methylphenyl
D012486 Salmonella typhimurium A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER. Salmonella typhimurium LT2
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

M Shahin, and D Rouers, and A Bugaut, and G Kalopissis
May 1994, Mutation research,
M Shahin, and D Rouers, and A Bugaut, and G Kalopissis
July 2002, Bioorganic & medicinal chemistry,
M Shahin, and D Rouers, and A Bugaut, and G Kalopissis
January 1990, The Journal of pharmacology and experimental therapeutics,
M Shahin, and D Rouers, and A Bugaut, and G Kalopissis
August 2005, Bioorganic & medicinal chemistry letters,
M Shahin, and D Rouers, and A Bugaut, and G Kalopissis
November 1985, Toxicology letters,
M Shahin, and D Rouers, and A Bugaut, and G Kalopissis
April 1973, British journal of pharmacology,
M Shahin, and D Rouers, and A Bugaut, and G Kalopissis
October 2003, Bioorganic & medicinal chemistry letters,
M Shahin, and D Rouers, and A Bugaut, and G Kalopissis
July 1990, Die Pharmazie,
M Shahin, and D Rouers, and A Bugaut, and G Kalopissis
January 1992, The Journal of antibiotics,
M Shahin, and D Rouers, and A Bugaut, and G Kalopissis
January 1985, Arzneimittel-Forschung,
Copied contents to your clipboard!